| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.
|
Arch Intern Med
|
2002
|
2.24
|
|
2
|
Interplay in the selection of fluoroquinolone resistance and bacterial fitness.
|
PLoS Pathog
|
2009
|
2.21
|
|
3
|
Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples.
|
J Clin Microbiol
|
2013
|
1.86
|
|
4
|
Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.
|
PLoS One
|
2010
|
1.77
|
|
5
|
Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation.
|
Virulence
|
2011
|
1.64
|
|
6
|
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
|
J Antimicrob Chemother
|
2013
|
1.60
|
|
7
|
Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
|
J Antimicrob Chemother
|
2013
|
1.56
|
|
8
|
In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers.
|
Antimicrob Agents Chemother
|
2006
|
1.55
|
|
9
|
Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.
|
J Antimicrob Chemother
|
2010
|
1.51
|
|
10
|
Comment on: withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health.
|
Int J Antimicrob Agents
|
2007
|
1.48
|
|
11
|
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.
|
Antimicrob Agents Chemother
|
2005
|
1.47
|
|
12
|
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
|
Microb Drug Resist
|
2008
|
1.34
|
|
13
|
Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients.
|
Int J Food Microbiol
|
2010
|
1.24
|
|
14
|
Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes?
|
Microb Drug Resist
|
2004
|
1.23
|
|
15
|
Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection.
|
Foodborne Pathog Dis
|
2010
|
1.18
|
|
16
|
Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
|
J Infect Dis
|
2008
|
1.18
|
|
17
|
Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000.
|
Pediatr Infect Dis J
|
2007
|
1.14
|
|
18
|
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
|
Antimicrob Agents Chemother
|
2008
|
1.13
|
|
19
|
Detection of sul1, sul2 and sul3 in sulphonamide resistant Escherichia coli isolates obtained from healthy humans, pork and pigs in Denmark.
|
Int J Food Microbiol
|
2005
|
1.11
|
|
20
|
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
|
Antimicrob Agents Chemother
|
2010
|
1.06
|
|
21
|
Danish integrated antimicrobial resistance monitoring and research program.
|
Emerg Infect Dis
|
2007
|
1.04
|
|
22
|
Antimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs.
|
Chembiochem
|
2010
|
1.03
|
|
23
|
Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine.
|
J Antimicrob Chemother
|
2008
|
1.03
|
|
24
|
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
|
Antimicrob Agents Chemother
|
2009
|
1.02
|
|
25
|
Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates.
|
J Bacteriol
|
2004
|
0.98
|
|
26
|
Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.
|
Infect Immun
|
2014
|
0.97
|
|
27
|
Validation of FLEXICULT SSI-Urinary Kit for use in the primary health care setting.
|
Scand J Infect Dis
|
2002
|
0.97
|
|
28
|
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
|
Clin Infect Dis
|
2012
|
0.97
|
|
29
|
Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi.
|
Chemotherapy
|
2008
|
0.94
|
|
30
|
Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.
|
Antimicrob Agents Chemother
|
2003
|
0.94
|
|
31
|
Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection.
|
J Med Microbiol
|
2014
|
0.93
|
|
32
|
Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis.
|
BMC Infect Dis
|
2006
|
0.93
|
|
33
|
Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro.
|
J Antimicrob Chemother
|
2010
|
0.93
|
|
34
|
Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
|
J Antimicrob Chemother
|
2012
|
0.92
|
|
35
|
Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors.
|
J Infect
|
2009
|
0.92
|
|
36
|
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
|
Int J Antimicrob Agents
|
2013
|
0.90
|
|
37
|
Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.
|
Infect Immun
|
2004
|
0.89
|
|
38
|
Virulence of Escherichia coli B2 isolates from meat and animals in a murine model of ascending urinary tract infection (UTI): evidence that UTI is a zoonosis.
|
J Clin Microbiol
|
2010
|
0.89
|
|
39
|
Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin.
|
J Med Microbiol
|
2011
|
0.89
|
|
40
|
Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
|
J Antimicrob Chemother
|
2010
|
0.89
|
|
41
|
In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging.
|
BMC Med Imaging
|
2008
|
0.89
|
|
42
|
Characterisation, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment.
|
Environ Int
|
2007
|
0.88
|
|
43
|
Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin.
|
Int J Med Microbiol
|
2012
|
0.88
|
|
44
|
Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model.
|
Appl Environ Microbiol
|
2010
|
0.88
|
|
45
|
Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic.
|
J Antimicrob Chemother
|
2012
|
0.88
|
|
46
|
Vancomycin-resistant Enterococcus faecalis isolates from a Danish patient and two healthy human volunteers are possibly related to isolates from imported turkey meat.
|
J Antimicrob Chemother
|
2008
|
0.87
|
|
47
|
Penicillin resistance and serotype distribution of Streptococcus pneumoniae in Ghanaian children less than six years of age.
|
BMC Infect Dis
|
2013
|
0.87
|
|
48
|
Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
|
Microb Drug Resist
|
2011
|
0.87
|
|
49
|
Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis.
|
J Appl Physiol (1985)
|
2006
|
0.87
|
|
50
|
Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.
|
Antimicrob Agents Chemother
|
2011
|
0.86
|
|
51
|
The more antibacterial trade names, the more consumption of antibacterials: a European study.
|
Clin Infect Dis
|
2005
|
0.86
|
|
52
|
Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals.
|
J Antimicrob Chemother
|
2008
|
0.86
|
|
53
|
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
|
J Med Chem
|
2012
|
0.86
|
|
54
|
Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
|
J Neuroimmunol
|
2005
|
0.86
|
|
55
|
High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis.
|
Antimicrob Agents Chemother
|
2009
|
0.86
|
|
56
|
Prevalence of sulphonamide resistance and class 1 integron genes in Escherichia coli isolates obtained from broilers, broiler meat, healthy humans and urinary infections in Denmark.
|
Int J Antimicrob Agents
|
2008
|
0.85
|
|
57
|
Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance.
|
Scand J Infect Dis
|
2012
|
0.85
|
|
58
|
Structure--activity study of the antibacterial peptide fallaxin.
|
Protein Sci
|
2007
|
0.85
|
|
59
|
Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women.
|
J Med Microbiol
|
2010
|
0.85
|
|
60
|
The effect of S. pneumoniae bacteremia on cerebral blood flow autoregulation in rats.
|
J Cereb Blood Flow Metab
|
2007
|
0.84
|
|
61
|
Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period.
|
Acta Derm Venereol
|
2008
|
0.84
|
|
62
|
Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice.
|
J Antimicrob Chemother
|
2010
|
0.84
|
|
63
|
Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.
|
Int J Antimicrob Agents
|
2011
|
0.84
|
|
64
|
Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model.
|
Antimicrob Agents Chemother
|
2009
|
0.83
|
|
65
|
Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis.
|
J Antimicrob Chemother
|
2006
|
0.83
|
|
66
|
Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
|
J Antimicrob Chemother
|
2010
|
0.82
|
|
67
|
Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.
|
Antimicrob Agents Chemother
|
2010
|
0.82
|
|
68
|
Beta-hemolytic streptococcal bacteremia: a review of 241 cases.
|
Scand J Infect Dis
|
2002
|
0.82
|
|
69
|
Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics.
|
Antimicrob Agents Chemother
|
2009
|
0.81
|
|
70
|
Synthetic analogs of anoplin show improved antimicrobial activities.
|
J Pept Sci
|
2013
|
0.80
|
|
71
|
Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis.
|
Laryngoscope
|
2009
|
0.80
|
|
72
|
Consequences of increased antibacterial consumption and change in pattern of antibacterial use in Danish hospitals.
|
J Antimicrob Chemother
|
2009
|
0.80
|
|
73
|
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
|
J Med Chem
|
2014
|
0.79
|
|
74
|
The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
|
APMIS
|
2008
|
0.79
|
|
75
|
Characterization and transfer studies of macrolide resistance genes in Streptococcus pneumoniae from Denmark.
|
Scand J Infect Dis
|
2010
|
0.78
|
|
76
|
[Use of antibiotics in colorectal surgery in Denmark].
|
Ugeskr Laeger
|
2007
|
0.78
|
|
77
|
Silver resistance: an alarming public health concern?
|
Int J Antimicrob Agents
|
2011
|
0.78
|
|
78
|
Association between antimicrobial resistance and virulence genes in Escherichia coli obtained from blood and faeces.
|
Scand J Infect Dis
|
2007
|
0.78
|
|
79
|
Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countries.
|
Scand J Infect Dis
|
2011
|
0.78
|
|
80
|
In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
|
APMIS
|
2002
|
0.78
|
|
81
|
Tentative interpretative zone diameters for fusidic acid Neosensitabs on Mueller Hinton agar and three blood containing media.
|
Int J Antimicrob Agents
|
2003
|
0.77
|
|
82
|
Evaluation of different disk diffusion/media combinations for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci.
|
APMIS
|
2003
|
0.77
|
|
83
|
Nasopharyngeal pathogens in children with acute otitis media in a low-antibiotic use country.
|
Int J Pediatr Otorhinolaryngol
|
2004
|
0.76
|
|
84
|
[Diagnosis of streptococcal tonsillitis in the pediatric department with the help of antigen detection test].
|
Ugeskr Laeger
|
2003
|
0.76
|
|
85
|
Only percentage within species; neither incidence, nor prevalence: demographic information and representative surveillance data are urgently needed to estimate the burden of antimicrobial resistance.
|
Int J Antimicrob Agents
|
2004
|
0.76
|
|
86
|
[Contribution to a debate on Cochrane analysis].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
87
|
Food safety revisited.
|
J Infect Dis
|
2006
|
0.75
|
|
88
|
[Can we rely on the results of urine microscopy and culture when tests are performed in general practice? 1].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
89
|
[Can we rely on the results of urine microscopy?].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
90
|
High prevalence of macrolide resistance: not in every country! [Comment on: Halpern et al. J Antimicrob Chemother 2005; 55: 748-57].
|
J Antimicrob Chemother
|
2005
|
0.75
|
|
91
|
[Aminoglycosides to critically ill patients--and others].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
92
|
[Strengthening of laboratories is a new component in the global strategy for tuberculosis control].
|
Ugeskr Laeger
|
2011
|
0.75
|
|
93
|
Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
|
J Antimicrob Chemother
|
2003
|
0.75
|
|
94
|
Unusual pathogenic B1 genotype (yjaA/TspE4.C2) detected among Escherichia coli from pig, chicken broiler meat and human extraintestinal infection.
|
J Med Microbiol
|
2013
|
0.75
|
|
95
|
Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011.
|
Scand J Infect Dis
|
2014
|
0.75
|
|
96
|
[Antibiotics and overweight].
|
Ugeskr Laeger
|
2005
|
0.75
|
|
97
|
[Staphylococcus aureus infections--the clinical picture and treatment].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
98
|
[Elderly patients suffer more from side effects and resistant microorganisms].
|
Ugeskr Laeger
|
2013
|
0.75
|
|
99
|
[Hospital infections--knowledge before action].
|
Ugeskr Laeger
|
2011
|
0.75
|
|
100
|
Infectious endocarditis caused by Escherichia coli.
|
Scand J Infect Dis
|
2011
|
0.75
|
|
101
|
[Increasing transmission of antibiotic resistance from animals to humans].
|
Ugeskr Laeger
|
2011
|
0.75
|
|
102
|
[Sulfamethizole versus pivmecillinam in urinary tract infections].
|
Ugeskr Laeger
|
2003
|
0.75
|
|
103
|
[Correct dosage of antibiotics. The Danish Society of Clinical Microbiology].
|
Ugeskr Laeger
|
2007
|
0.75
|